Swixx BioPharma International

Swixx BioPharma International is owned by Swixx BioPharma.

Swixx BioPharma is a company listed under the stock ticker SIX (CH).

View the org chart displaying its 9 main executives

Most searched biographies at Swixx BioPharma International

• Martina Bergant, General Manager, Slovenia
• Davor Kovaäeviä, ‡General Manager, Croatia and Slovenia
• George Bithas, General Manager Greece, Cyprus and Malta

Create your alert
to follow the executive moves at Swixx BioPharma International.

Swixx BioPharma has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Swixx BioPharma International

Social media about Swixx BioPharma International

• Swixx BioPharma International on Wikipedia, Google News & Yahoo Finance
• Swixx BioPharma International on LinkedIn, Twitter & YouTube

Contact by email its executives including George Bithas

Call Swixx BioPharma International at +41 41...

View the org chart

Register to receive your alert

Report an error